, Tracking Stock Market Picks
Enter Symbol:
Oncogenex Technologies Inc. (OGXI) [hlAlert]

down 42.00 %

Oncogenex Technologies Inc. (OGXI) rated Outperform with price target $36 by RBC Capital Mkts

Posted on: Friday,  Oct 22, 2010  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Oncogenex Technologies Inc. (NASDAQ: OGXI) on 10/22/2010. Previously RBC Capital Mkts rated Outperform Oncogenex Technologies Inc. (NASDAQ: OGXI)
on 09/19/2008., when the stock price was $4.50. Since then, Oncogenex Technologies Inc. has lost 42.00% as of 01/22/2016's recent price of $2.61.
If you would have followed the previous RBC Capital Mkts's recommendation on OGXI, you would have lost 42% of your investment in 2681 days.

OncoGenex Pharmaceuticals Inc., formerly Sonus Pharmaceuticals, Inc., is a biopharmaceutical company engaged in the development and commercialization of cancer therapies that address treatment resistance in cancer patients. The Company has five product candidates in its pipeline, with each product candidate having a distinct mechanism of action and representing an opportunity for cancer drug development. OncoGenex? product candidates OGX-011, OGX-427 and OGX-225 focus on mechanisms of treatment resistance in cancer patients and are designed to address treatment resistance by blocking the production of specific proteins. Product candidate SN2310 is a camptothecin for the treatment of cancer. Camptothecins are potent anticancer agents that belong to the family of drugs called topoisomerase I inhibitors that bind reversibly to the TOPO-I-DNA complex causing breaks in the DNA strands during replication resulting in cell death.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/22/2010 9:25 AM Buy
17.34 36.00
as of 12/31/2010
1 Week up  3.38 %
1 Month up  2.73 %
3 Months up  11.11 %
1 YTD down  -25.94 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2009 8:25 AM Buy
9/19/2008 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy